ID   SIK2_HUMAN              Reviewed;         926 AA.
AC   Q9H0K1; A8K5B8; B0YJ94; O94878; Q17RV0; Q6AZE2; Q76N03; Q8NCV7; Q96CZ8;
DT   15-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   12-OCT-2022, entry version 184.
DE   RecName: Full=Serine/threonine-protein kinase SIK2;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:24129571};
DE   AltName: Full=Qin-induced kinase;
DE   AltName: Full=Salt-inducible kinase 2;
DE            Short=SIK-2;
DE   AltName: Full=Serine/threonine-protein kinase SNF1-like kinase 2;
GN   Name=SIK2;
GN   Synonyms=KIAA0781 {ECO:0000312|EMBL:BAA34501.3}, QIK, SNF1LK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], ACTIVITY REGULATION, PHOSPHORYLATION AT
RP   THR-175, AND MUTAGENESIS OF THR-175.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A., Boudeau J.,
RA   Hawley S.A., Udd L., Maekelae T.P., Hardie D.G., Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily,
RT   including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:BAA34501.3}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000312|EMBL:BAA34501.3};
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [3] {ECO:0000305}
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:CAB66698.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:BAB91442.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000305, ECO:0000312|EMBL:BAB91442.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8] {ECO:0000305, ECO:0000312|EMBL:AAH78150.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, Lung {ECO:0000312|EMBL:AAH13612.1}, and Testis
RC   {ECO:0000312|EMBL:AAH78150.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9] {ECO:0000305, ECO:0000312|EMBL:BAB91442.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-926.
RA   Takemori H.;
RT   "A cDNA fragment encoding an active serine-kinase, Homo sapiens KIAA0781
RT   protein.";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   INTERACTION WITH CRTC2, AND FUNCTION.
RX   PubMed=15454081; DOI=10.1016/j.cell.2004.09.015;
RA   Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G.,
RA   Jeffries S., Guzman E., Niessen S., Yates J.R. III, Takemori H.,
RA   Okamoto M., Montminy M.;
RT   "The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive
RT   coincidence detector.";
RL   Cell 119:61-74(2004).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-587, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-25, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-587, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   FUNCTION.
RX   PubMed=21084751; DOI=10.1172/jci41624;
RA   Bricambert J., Miranda J., Benhamed F., Girard J., Postic C., Dentin R.;
RT   "Salt-inducible kinase 2 links transcriptional coactivator p300
RT   phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in
RT   mice.";
RL   J. Clin. Invest. 120:4316-4331(2010).
RN   [15]
RP   ACETYLATION AT LYS-53, AND FUNCTION.
RX   PubMed=23322770; DOI=10.1074/jbc.m112.431239;
RA   Yang F.C., Tan B.C., Chen W.H., Lin Y.H., Huang J.Y., Chang H.Y., Sun H.Y.,
RA   Hsu P.H., Liou G.G., Shen J., Chang C.J., Han C.C., Tsai M.D., Lee S.C.;
RT   "Reversible acetylation regulates salt-inducible kinase (SIK2) and its
RT   function in autophagy.";
RL   J. Biol. Chem. 288:6227-6237(2013).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND CATALYTIC ACTIVITY.
RX   PubMed=24129571; DOI=10.1074/jbc.m113.492199;
RA   Yang F.C., Lin Y.H., Chen W.H., Huang J.Y., Chang H.Y., Su S.H., Wang H.T.,
RA   Chiang C.Y., Hsu P.H., Tsai M.D., Tan B.C., Lee S.C.;
RT   "Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-
RT   containing protein (VCP) regulates endoplasmic reticulum (ER)-associated
RT   protein degradation in mammalian cells.";
RL   J. Biol. Chem. 288:33861-33872(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-587, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-587, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   FUNCTION.
RX   PubMed=26983400; DOI=10.1038/srep23317;
RA   Zhang Z.N., Gong L., Lv S., Li J., Tai X., Cao W., Peng B., Qu S., Li W.,
RA   Zhang C., Luan B.;
RT   "SIK2 regulates fasting-induced PPARalpha activity and ketogenesis through
RT   p300.";
RL   Sci. Rep. 6:23317-23317(2016).
RN   [20]
RP   PHOSPHORYLATION AT THR-484.
RX   PubMed=30586628; DOI=10.1016/j.cellsig.2018.12.011;
RA   Saell J., Negoita F., Hansson B., Kopietz F., Linder W., Pettersson A.M.L.,
RA   Ekelund M., Laurencikiene J., Degerman E., Stenkula K.G., Goeransson O.;
RT   "Insulin induces Thr484 phosphorylation and stabilization of SIK2 in
RT   adipocytes.";
RL   Cell. Signal. 55:73-80(2019).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-458; GLN-809 AND LEU-825.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase that plays a role in many
CC       biological processes such as fatty acid oxidation, autophagy, immune
CC       response or glucose metabolism (PubMed:23322770, PubMed:26983400).
CC       Phosphorylates 'Ser-794' of IRS1 in insulin-stimulated adipocytes,
CC       potentially modulating the efficiency of insulin signal transduction.
CC       Inhibits CREB activity by phosphorylating and repressing TORCs, the
CC       CREB-specific coactivators (PubMed:15454081). Phosphorylates EP300 and
CC       thus inhibits its histone acetyltransferase activity (PubMed:21084751,
CC       PubMed:26983400). In turn, regulates the DNA-binding ability of several
CC       transcription factors such as PPARA or MLXIPL (PubMed:21084751,
CC       PubMed:26983400). Also plays a role in thymic T-cell development (By
CC       similarity). {ECO:0000250|UniProtKB:Q8CFH6,
CC       ECO:0000269|PubMed:15454081, ECO:0000269|PubMed:21084751,
CC       ECO:0000269|PubMed:23322770, ECO:0000269|PubMed:26983400}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:24129571};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:14976552};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:14976552};
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation on Thr-175.
CC       {ECO:0000269|PubMed:14976552}.
CC   -!- SUBUNIT: Interacts with and phosphorylates TORC2/CRTC2.
CC       {ECO:0000269|PubMed:15454081}.
CC   -!- INTERACTION:
CC       Q9H0K1; Q9BV73: CEP250; NbExp=5; IntAct=EBI-1181664, EBI-1053100;
CC       Q9H0K1; P60520: GABARAPL2; NbExp=3; IntAct=EBI-1181664, EBI-720116;
CC       Q9H0K1; P27986: PIK3R1; NbExp=7; IntAct=EBI-1181664, EBI-79464;
CC       Q9H0K1; P55072: VCP; NbExp=4; IntAct=EBI-1181664, EBI-355164;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Endoplasmic reticulum
CC       membrane {ECO:0000269|PubMed:24129571}.
CC   -!- PTM: Phosphorylated at Thr-175 by STK11/LKB1 in complex with STE20-
CC       related adapter-alpha (STRADA) pseudo kinase and CAB39
CC       (PubMed:14976552). Phosphorylated at Thr-484 in response to insulin in
CC       adipocytes (PubMed:30586628). {ECO:0000269|PubMed:14976552,
CC       ECO:0000269|PubMed:30586628}.
CC   -!- PTM: Acetylation at Lys-53 inhibits kinase activity. Deacetylated by
CC       HDAC6. {ECO:0000269|PubMed:23322770}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA34501.3; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB018324; BAA34501.3; ALT_INIT; mRNA.
DR   EMBL; AL136764; CAB66698.1; -; mRNA.
DR   EMBL; AK291233; BAF83922.1; -; mRNA.
DR   EMBL; EF445030; ACA06072.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67148.1; -; Genomic_DNA.
DR   EMBL; BC013612; AAH13612.1; -; mRNA.
DR   EMBL; BC078150; AAH78150.1; -; mRNA.
DR   EMBL; BC113459; AAI13460.1; -; mRNA.
DR   EMBL; BC117183; AAI17184.1; -; mRNA.
DR   EMBL; AB084424; BAB91442.1; -; mRNA.
DR   CCDS; CCDS8347.1; -.
DR   RefSeq; NP_056006.1; NM_015191.2.
DR   AlphaFoldDB; Q9H0K1; -.
DR   SMR; Q9H0K1; -.
DR   BioGRID; 116840; 96.
DR   IntAct; Q9H0K1; 30.
DR   STRING; 9606.ENSP00000305976; -.
DR   BindingDB; Q9H0K1; -.
DR   ChEMBL; CHEMBL5699; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9H0K1; -.
DR   GuidetoPHARMACOLOGY; 2198; -.
DR   GlyGen; Q9H0K1; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9H0K1; -.
DR   PhosphoSitePlus; Q9H0K1; -.
DR   BioMuta; SIK2; -.
DR   DMDM; 59798973; -.
DR   EPD; Q9H0K1; -.
DR   jPOST; Q9H0K1; -.
DR   MassIVE; Q9H0K1; -.
DR   MaxQB; Q9H0K1; -.
DR   PaxDb; Q9H0K1; -.
DR   PeptideAtlas; Q9H0K1; -.
DR   PRIDE; Q9H0K1; -.
DR   ProteomicsDB; 80290; -.
DR   Antibodypedia; 18251; 309 antibodies from 33 providers.
DR   DNASU; 23235; -.
DR   Ensembl; ENST00000304987.4; ENSP00000305976.3; ENSG00000170145.5.
DR   GeneID; 23235; -.
DR   KEGG; hsa:23235; -.
DR   MANE-Select; ENST00000304987.4; ENSP00000305976.3; NM_015191.3; NP_056006.1.
DR   UCSC; uc001plt.4; human.
DR   CTD; 23235; -.
DR   DisGeNET; 23235; -.
DR   GeneCards; SIK2; -.
DR   HGNC; HGNC:21680; SIK2.
DR   HPA; ENSG00000170145; Low tissue specificity.
DR   MIM; 608973; gene.
DR   neXtProt; NX_Q9H0K1; -.
DR   OpenTargets; ENSG00000170145; -.
DR   PharmGKB; PA164725750; -.
DR   VEuPathDB; HostDB:ENSG00000170145; -.
DR   eggNOG; KOG0586; Eukaryota.
DR   GeneTree; ENSGT00940000156445; -.
DR   HOGENOM; CLU_000288_87_0_1; -.
DR   InParanoid; Q9H0K1; -.
DR   OMA; QTVGPPM; -.
DR   OrthoDB; 1127668at2759; -.
DR   PhylomeDB; Q9H0K1; -.
DR   TreeFam; TF315213; -.
DR   PathwayCommons; Q9H0K1; -.
DR   SignaLink; Q9H0K1; -.
DR   SIGNOR; Q9H0K1; -.
DR   BioGRID-ORCS; 23235; 11 hits in 1110 CRISPR screens.
DR   ChiTaRS; SIK2; human.
DR   GeneWiki; SNF1LK2; -.
DR   GenomeRNAi; 23235; -.
DR   Pharos; Q9H0K1; Tchem.
DR   PRO; PR:Q9H0K1; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9H0K1; protein.
DR   Bgee; ENSG00000170145; Expressed in choroid plexus epithelium and 216 other tissues.
DR   ExpressionAtlas; Q9H0K1; baseline and differential.
DR   Genevisible; Q9H0K1; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0046626; P:regulation of insulin receptor signaling pathway; ISS:UniProtKB.
DR   CDD; cd14071; STKc_SIK; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR017090; Ser/Thr_kinase_SIK1/2.
DR   InterPro; IPR034672; SIK.
DR   InterPro; IPR015940; UBA.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037014; Ser/Thr_PK_SNF1-like; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cytoplasm; Endoplasmic reticulum; Kinase;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..926
FT                   /note="Serine/threonine-protein kinase SIK2"
FT                   /id="PRO_0000086662"
FT   DOMAIN          20..271
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          295..335
FT                   /note="UBA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00212"
FT   REGION          644..666
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          742..776
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          801..896
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        752..767
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        801..816
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        817..838
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        142
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q13131,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10027"
FT   BINDING         26..34
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q13131,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         49
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CFH6,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         25
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         53
FT                   /note="N6-acetyllysine; by EP300"
FT                   /evidence="ECO:0000269|PubMed:23322770"
FT   MOD_RES         175
FT                   /note="Phosphothreonine; by LKB1"
FT                   /evidence="ECO:0000269|PubMed:14976552"
FT   MOD_RES         484
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:30586628"
FT   MOD_RES         534
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CFH6"
FT   MOD_RES         587
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   VARIANT         458
FT                   /note="T -> I (in dbSNP:rs35789057)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041093"
FT   VARIANT         809
FT                   /note="R -> Q (in dbSNP:rs34223841)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041094"
FT   VARIANT         825
FT                   /note="P -> L (in dbSNP:rs55889697)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041095"
FT   VARIANT         828
FT                   /note="P -> L (in dbSNP:rs45520245)"
FT                   /id="VAR_051667"
FT   VARIANT         829
FT                   /note="P -> S (in dbSNP:rs45586732)"
FT                   /id="VAR_051668"
FT   MUTAGEN         175
FT                   /note="T->A: Prevents phosphorylation and activation by
FT                   STK11/LKB1 complex."
FT                   /evidence="ECO:0000269|PubMed:14976552"
FT   MUTAGEN         175
FT                   /note="T->E: Constitutively active."
FT                   /evidence="ECO:0000269|PubMed:14976552"
FT   CONFLICT        192
FT                   /note="Q -> H (in Ref. 5; BAF83922)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        463
FT                   /note="E -> V (in Ref. 5; BAF83922)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   926 AA;  103915 MW;  9D7F9BF81FD65CCF CRC64;
     MVMADGPRHL QRGPVRVGFY DIEGTLGKGN FAVVKLGRHR ITKTEVAIKI IDKSQLDAVN
     LEKIYREVQI MKMLDHPHII KLYQVMETKS MLYLVTEYAK NGEIFDYLAN HGRLNESEAR
     RKFWQILSAV DYCHGRKIVH RDLKAENLLL DNNMNIKIAD FGFGNFFKSG ELLATWCGSP
     PYAAPEVFEG QQYEGPQLDI WSMGVVLYVL VCGALPFDGP TLPILRQRVL EGRFRIPYFM
     SEDCEHLIRR MLVLDPSKRL TIAQIKEHKW MLIEVPVQRP VLYPQEQENE PSIGEFNEQV
     LRLMHSLGID QQKTIESLQN KSYNHFAAIY FLLVERLKSH RSSFPVEQRL DGRQRRPSTI
     AEQTVAKAQT VGLPVTMHSP NMRLLRSALL PQASNVEAFS FPASGCQAEA AFMEEECVDT
     PKVNGCLLDP VPPVLVRKGC QSLPSNMMET SIDEGLETEG EAEEDPAHAF EAFQSTRSGQ
     RRHTLSEVTN QLVVMPGAGK IFSMNDSPSL DSVDSEYDMG SVQRDLNFLE DNPSLKDIML
     ANQPSPRMTS PFISLRPTNP AMQALSSQKR EVHNRSPVSF REGRRASDTS LTQGIVAFRQ
     HLQNLARTKG ILELNKVQLL YEQIGPEADP NLAPAAPQLQ DLASSCPQEE VSQQQESVST
     LPASVHPQLS PRQSLETQYL QHRLQKPSLL SKAQNTCQLY CKEPPRSLEQ QLQEHRLQQK
     RLFLQKQSQL QAYFNQMQIA ESSYPQPSQQ LPLPRQETPP PSQQAPPFSL TQPLSPVLEP
     SSEQMQYSPF LSQYQEMQLQ PLPSTSGPRA APPLPTQLQQ QQPPPPPPPP PPRQPGAAPA
     PLQFSYQTCE LPSAASPAPD YPTPCQYPVD GAQQSDLTGP DCPRSPGLQE APSSYDPLAL
     SELPGLFDCE MLDAVDPQHN GYVLVN
//
